• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Opinion

Video

Case 1: Female, 23 Years Old

Heather C Woolery-Lloyd, MD, discusses a 23-year-old woman with vitiligo vulgaris affecting 75% of her face, including complete depigmentation. She explores the panel’s response to managing progressive disease and its impact on the patient's quality of life.

Panelists:

Heather C Woolery-Lloyd, MD

University of Miami

Miami, Florida

Program Description:

An expert in dermatology provides insights from a case-based roundtable conversation, discussing the management vitiligo across diverse age groups and skin types. The discussion centers on understanding the challenges posed by vitiligo, addressing its impact on patients' well-being. The conversation emphasizes effective education and communication strategies and shines a spotlight on the intricacies of treating non-facial areas.

Segment Description:

Heather C Woolery-Lloyd, MD, discusses a 23-year-old woman with vitiligo vulgaris affecting 75% of her face, including complete depigmentation. She explores the panel’s response to managing progressive disease and its impact on the patient's quality of life.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.